基尿素不能逆转氧化物-cGMP通路的功能性改变与状细胞小鼠状细胞体中priapism表型相关
Dalila Andrade Pereira1, Danillo Andrade Pereira1, Pamela da Silva Pereira2
1Laboratory of Pharmacology, São Francisco University Medical School, Bragança Paulista, São Paulo, Brazil.
PloS one
|October 9, 2023
概括
基尿素不能有效地治疗状细胞疾病 (SCD) 的小鼠中的priapism. 这很可能是由于血红蛋白过多和活性氧物种干扰了SCD中的氧化信号传输. 需要使用替代疗法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 遗传学 是一个遗传学.
背景情况:
- 状细胞疾病 (SCD) 与嗜食症有关.
- 氨酸对氧化物 (NO) -cGMP途径在SCD相关的青症的影响还不清楚.
研究的目的:
- 为了研究素尿素对SCD和内皮NO合成酶基因缺陷 (eNOS-/-) 的SCD和内皮NO合成酶基因缺陷 (eNOS-/-) 鼠标模型中肉肌肉光滑肌肉放松的影响.
主要方法:
- 野生类型的雄性,SCD转基因和eNOS/-小鼠被用氨酸素或载体治疗.
- 对乙胆,酸和电场刺激的度-反应曲线是使用体洞穴状体条纹生成的.
主要成果:
- SCD小鼠对乙胆,酸和电场刺激表现出放大放松反应.
- eNOS-/-小鼠对酸和电场刺激有较强的放松反应.
- 在SCD或eNOS-/-小鼠中,基尿素治疗没有改变这些放松反应.
结论:
- 氧尿素在治疗状细胞疾病中的priapism是无效的.
- 在SCD中过多的血红蛋白和活性氧物种可能会干扰NO信号,阻碍氧尿素的有效性.
- 迫切需要替代治疗策略用于SCD中的priapism.
相关概念视频
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
169
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
169
Antihypertensive Drugs: Vasodilators
548
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
548


